[Diagnosis and therapy for progressive supranuclear palsy and corticobasal degeneration].
D017668:Age of Onset; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001479:Basal Ganglia / Q000473:pathology; D001569:Benzodiazepines; D002540:Cerebral Cortex / Q000473:pathology; D003952:Diagnostic Imaging; D018491:Dopamine Agonists / Q000627:therapeutic use; D006801:Humans; D019636:Neurodegenerative Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D012015:Reference Standards; D013494:Supranuclear Palsy, Progressive / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology
D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D018491:Dopamine Agonists; D001569:Benzodiazepines